Free Trial

Simulations Plus (SLP) Competitors

Simulations Plus logo
$13.23 +0.11 (+0.84%)
Closing price 04:00 PM Eastern
Extended Trading
$13.28 +0.04 (+0.34%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SLP vs. ENFN, PD, TUYA, COUR, IAS, BASE, SEMR, MLNK, AMPL, and SABR

Should you be buying Simulations Plus stock or one of its competitors? The main competitors of Simulations Plus include Enfusion (ENFN), PagerDuty (PD), Tuya (TUYA), Coursera (COUR), Integral Ad Science (IAS), Couchbase (BASE), Semrush (SEMR), MeridianLink (MLNK), Amplitude (AMPL), and Sabre (SABR). These companies are all part of the "computer software" industry.

Simulations Plus vs. Its Competitors

Simulations Plus (NASDAQ:SLP) and Enfusion (NYSE:ENFN) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

78.1% of Simulations Plus shares are owned by institutional investors. Comparatively, 81.1% of Enfusion shares are owned by institutional investors. 19.4% of Simulations Plus shares are owned by insiders. Comparatively, 36.4% of Enfusion shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Enfusion has a net margin of 1.70% compared to Simulations Plus' net margin of -78.63%. Simulations Plus' return on equity of 11.62% beat Enfusion's return on equity.

Company Net Margins Return on Equity Return on Assets
Simulations Plus-78.63% 11.62% 10.84%
Enfusion 1.70%6.67%4.86%

Simulations Plus currently has a consensus target price of $26.50, suggesting a potential upside of 100.30%. Enfusion has a consensus target price of $12.25, suggesting a potential upside of 12.91%. Given Simulations Plus' stronger consensus rating and higher possible upside, analysts clearly believe Simulations Plus is more favorable than Enfusion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Simulations Plus
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Enfusion
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Simulations Plus has higher earnings, but lower revenue than Enfusion. Simulations Plus is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Simulations Plus$70.01M3.80$9.95M-$3.15-4.20
Enfusion$201.61M6.94$6.03M$0.03361.63

In the previous week, Simulations Plus had 12 more articles in the media than Enfusion. MarketBeat recorded 12 mentions for Simulations Plus and 0 mentions for Enfusion. Simulations Plus' average media sentiment score of 0.35 beat Enfusion's score of 0.00 indicating that Simulations Plus is being referred to more favorably in the media.

Company Overall Sentiment
Simulations Plus Neutral
Enfusion Neutral

Simulations Plus has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Summary

Simulations Plus and Enfusion tied by winning 8 of the 16 factors compared between the two stocks.

Get Simulations Plus News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLP vs. The Competition

MetricSimulations PlusCOMP IndustryComputer SectorNASDAQ Exchange
Market Cap$266.32M$167.90B$28.80B$9.51B
Dividend YieldN/A1.27%3.01%3.99%
P/E Ratio-4.2039.1834.1720.03
Price / Sales3.8010.901,720.63103.88
Price / Cash17.3028.8638.7059.01
Price / Book2.1510.377.795.90
Net Income$9.95M$3.72B$782.91M$258.66M
7 Day Performance6.18%1.41%0.97%2.23%
1 Month Performance-21.85%7.30%7.50%12.77%
1 Year Performance-66.50%37.58%53,041.27%19.36%

Simulations Plus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLP
Simulations Plus
4.458 of 5 stars
$13.23
+0.8%
$26.50
+100.3%
-66.8%$266.32M$70.01M-4.20160
ENFN
Enfusion
N/A$10.85
+0.5%
$12.25
+12.9%
+17.9%$1.40B$201.61M271.29890High Trading Volume
PD
PagerDuty
3.4318 of 5 stars
$14.95
+0.5%
$19.50
+30.5%
-27.2%$1.36B$467.50M-37.361,242Positive News
TUYA
Tuya
0.3493 of 5 stars
$2.52
+2.2%
N/A+62.8%$1.36B$298.62M62.891,435
COUR
Coursera
2.1675 of 5 stars
$8.33
+2.9%
$9.40
+12.9%
+25.9%$1.34B$694.67M-19.361,260Trending News
Earnings Report
Analyst Forecast
Options Volume
Gap Up
IAS
Integral Ad Science
3.1571 of 5 stars
$7.99
+1.9%
$13.55
+69.6%
-20.5%$1.32B$549.64M27.55760Positive News
Upcoming Earnings
Analyst Forecast
BASE
Couchbase
1.963 of 5 stars
$24.31
+0.0%
$23.09
-5.0%
+25.6%$1.31B$214.66M-17.74650
SEMR
Semrush
3.3855 of 5 stars
$8.73
+2.1%
$16.43
+88.3%
-31.9%$1.29B$396.02M109.091,170News Coverage
MLNK
MeridianLink
1.2481 of 5 stars
$16.33
+0.7%
$19.42
+18.9%
-28.5%$1.26B$316.30M-42.98620News Coverage
AMPL
Amplitude
1.9878 of 5 stars
$12.45
+3.2%
$13.50
+8.4%
+55.8%$1.23B$306.60M-16.38740
SABR
Sabre
1.4063 of 5 stars
$3.17
+0.3%
$4.28
+34.9%
+0.3%$1.23B$3.03B-7.206,253Trending News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:SLP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners